The "Cyclic" Regimen of Low-Dose Doxycycline for Adult Periodontitis: A Preliminary Study

Journal of Periodontology

Volumn 67, Issue 5, 1996, Pages 506-514

  Crout, R J ^a   Lee, H M ^b   Schroeder, K ^a   Crout, H ^a   Ramamurthy, N S ^b   Wiener, M ^c   Golub, L M ^b  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Collagenases; Double blind studies; Doxycycline; Gingival crevicular fluid; Periodontal attachment; Periodontitis diagnosis; Proteinase inhibitors

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANTIINFECTIVE AGENT; DOXYCYCLINE; MATRIX METALLOPROTEINASE INHIBITOR; PANCREATIC ELASTASE; SERINE PROTEINASE INHIBITOR;

ADULT; AGED; ANALYSIS OF VARIANCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; ENZYMOLOGY; FEMALE; GINGIVITIS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PERIODONTAL ATTACHMENT LOSS; PERIODONTITIS;

ADULT; AGED; ALPHA 1-ANTITRYPSIN; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; DOUBLE-BLIND METHOD; DOXYCYCLINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; MALE; MATRIX METALLOPROTEINASE INHIBITORS; MIDDLE AGED; PANCREATIC ELASTASE; PERIODONTAL ATTACHMENT LOSS; PERIODONTITIS; SERINE PROTEINASE INHIBITORS;

EID: 0030138722     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.1996.67.5.506     Document Type: Article

References (54)

1. Slots J, Mashimo P, Levine MJ, Genco RJ. Periodontal therapy in humans. I. Microbiological and clinical effects of a single course of periodontal scaling and root planing and of adjunctive tetracycline therapy. J Periodontol 1979;50:495-509.
2. Kornman KS, Karl EH. The effect of long-term low-dose tetracycline therapy on the subgingival microflora in refractory adult periodontitis. J Periodontol 1982;53:604-610.
3. Lindhe J, Liljenberg B, Adielsson B. Effect of long-term tetracycline therapy on human periodontal disease. J Clin Periodontol 1983;10:590-598.
4. Ciancio SG, Mather ML, McMullen JA. An evaluation of minocy- cline in patients with periodontal disease. J Periodontol 1980;51:530-534.
5. Novak MJ, Stamatelkys C, Adair SM. Resolution of early lesions of juvenile periodontitis with tetracycline therapy alone. J Periodontol 1991;62:628-633.
6. Slots J, Rams TE. Antibiotics in periodontal therapy: Advantages and disadvantages. J Clin Periodontol 1990;17:479-493.
7. Fiehn NE, Westergaard J. Doxycycline-resistant bacteria in periodontally-diseased individuals after systemic doxycycline therapy and in healthy individuals. Oral Microbiol Immunol 1990;5:219-222.
8. Olsvik B, Tenover FC. Tetracycline-resistance in periodontal pathogens. Clin Infect Dis 1993;16(Suppl. 4):S310-S313.
9. Golub LM, Ramamurthy NS, McNamara TE Greenwald RA, Rifkin BR. Tetracyclines inhibit connective tissue breakdown: New therapeutic implications for an old family of drugs. Crit Revs Oral Biol Med 1991;2:297-322.
10. Golub LM, Suomalaimen K, Sorsa T. Host modulation with tetracyclines and their chemically modified analogues. Curr Opin Dent 1992;2:80-90.
11. Golub LM, Wolff M, Roberts S, Lee HM, Leung M, Payonk GS. Treating periodontal diseases by blocking tissue-destructive enzymes. J Am Dent Assoc 1994;125:163-171.
12. Golub LM, Evans RT, McNamara TF, Lee HM, Ramamurthy NS. A non-antimicrobial tetracycline inhibits gingival matrix metallo-proteinases and bone loss in Porphyromonas gingivalis-induced periodontitis in rats. Ann NY Acad Sci 1994;732:96-111.
13. Rifkin BR, Vernillo AT, Golub LM. Blocking periodontal disease progression by inhibiting tissue-destructive enzymes: A potential therapeutic role for tetracyclines and their chemically-modified analogs. J Periodontol 1993;64:819-827.
14. Vernillo AT, Ramamurthy NS, Golub LM, Rifkin BR. The non-antimicrobial properties of tetracycline for the treatment of periodontal disease. Curr Opin Periodontol 1994;2:111-118.
15. Tilley BC, Alarcon GS, Heyse SP, et al. Minocycline in rheumatoid arthritis: A 48-week, double-blind, placebo-controlled trial. Ann Int Med 1995;122:81-89.
16. Sipos EP, Tamargo RJ, Weingart JD, Brem H. Inhibition of tumor angiogenesis. Ann NY Acad Sci 1994;732:263-272.
17. Brandt K. Modification by oral doxycycline administration of articular cartilage breakdown in osteoarthritis. J Rheumatol 1995;22(Suppl. 43):149-151.
18. Schneir M, Ramamurthy NS, Golub LM. Minocycline treatment of diabetic rats increases skin collagen production and mass. Matrix 1990;10:112-123.
19. Sasaki T, Ramamurthy NS, Golub LM. Tetracycline administration restores osteoblast structure and function during experimental diabetes. Anat Record 1991;231:25-34.
20. Golub LM, Ciancio S, Ramamurthy NS, Leung M, McNamara TE Low-dose doxycycline therapy: Effect on gingival and crevicular fluid collagenase activity in humans. J Periodont Res 1990;25:321-330.
21. Burns FR, Stack MS, Gray RD, Paterson CA. Inhibition of purified collagenase from alkali-burned rabbit corneas. Invest Ophthalmol Vis Sci 1989;30:1569-1575.
22. Bouwsma O, Payonk G, Baron H, Sipos T. Low-dose doxycycline effects on clinical parameters in adult periodontitis. J Dent Res 1992;71(Spec. Issue):245 (Abstr. 1119).
23. Schroeder K, Ramamurthy NS, Tofil P, Smith R, Lee HM, Golub LM. Low-dose doxycycline prevents attachment loss in adult periodontitis. J Dent Res 1992;71(Spec. Issue):758 (Abstr. 1936).
24. 1-proteinase inhibitor in gingival crevicular fluid and gingival tissue in adult and juvenile periodontitis. J Periodontol 1994;65:702-709.
25. Desroches PE, Jeffrey JJ, Weiss, SJ. Interstitial collagenase (MMP-1) expresses serpinase activity. J Clin Invest 1991;87:2258-2265.
26. Michaelis J, Vissers MCM, Winterbourn C. Human neutrophil collagenase cleaves alpha-1-antitrypsin. Biochem J 1990;270:809-815.
27. Turesky S, Gilmore N, Glickman I. Reduced plaque formation by the cholormethyl analogue of vitamin C. J Periodontol 1970;41:41-43.
28. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-135.
29. 3H-methyl] collagen. J Biochem Biophys Methods 1981;5:147-153.
30. Golub LM, Lee HM, Lehrer G, et al. Minocycline reduces gingival collagenolytic activity during diabetes: Preliminary observations and a proposed new mechanism of action. J Periodont Res 1983;18:516-526.
31. Golub LM, Wolff M, Lee HM, et al. Further evidence that tetracyclines inhibit collagenase activity in human crevicular fluid and from other mammalian sources. J Periodont Res 1985;20:12-23.
32. Zucker S, Wieman JM, Lysick RM, et al. Gelatin-degrading type IV collagenase isolated from human small cell lung cancer. Invasion Metast 1989;9:167-181.
33. 1-proteinase inhibitor in gingival crevicular fluid of humans with adult periodontitis: Serpinolytic inhibition by doxycycline. J Periodont Res 1996;31 accepted for publication.
34. Ramamurthy NS, Golub LM. Diabetes increases collagenase activity in extracts of rat gingiva and skin. J Periodont Res 1983;18:455-462.
35. Roscoe JT. Fundamental Research Statistics for Behaviour Science. New York: Holt, Rinehart and Winston, Inc; 1975:309-350.
36. 1-proteinase inhibitor binds to extracellular matrix in vitro with retention of inhibitory activity. Am J Respir Cell Mol Biol 1993;9:666-679.
37. Okada Y, Watanabe S, Nakanishi I, et al. Inaclivation of tissue inhibitor of metalloproteinases by neutrophil elastase and other serine proteinases. FEBS Lett 1988;229:157-160.
38. Steinmayer J, Daufeldt S, Kalbehn DA. Pharmacologic influence on the activity of stromelysin from bovine articular cartilage. Ann NY Acad Sci 1994;732:482-483.
39. Arsenis C, Greenwald RA, Moak SA, Laskin RS. Inhibition of neutral metalloproteinase activities in epiphyseal and articular cartilages by tetracyclines both in vivo and in vitro. Trans Orthoped Res Soc 1990;15:268 (Abstr.).
40. Golub LM, Greenwald RA, Ramamurthy NS, Zucker S, Ramsammy L, McNamara T. Tetracyclines inhibit matrix metalloproteinases (MMPs): In vivo effects in arthritic and diabetic rats and new in vitro studies. In: Birkedal-Hansen H, Werb Z, Welgus HG, Van Wart HE, eds. Matrix Metalloproteinases and Inhibitors. Stuttgart: Gustav Fischer Verlag; 1992:315-316.
41. Sorsa T, Lindy O, Konttinen YT, et al. Doxycycline in the protection of serum alpha-1-antitrypsin from human neutrophil collagenase and gelatinase. Antimicrob Agents Chemotherap 1993;37:592-594.
42. Sorsa T, Konttinen YT, Lindy O, et al. Doxycycline protects serum alpha-1-antitrypsin from human neutrophil collagenase. Joint Destr Arthritis Osteoarth (Basel) 1993;AA5 39:225-229.
43. Mallya SK, Hall JE, Lee HM, Roemer EJ, Simon SR, Golub LM. Interaction of matrix metalloproteinases with serine proteinase inhibitors: New potential roles for MMP inhibitors. Ann NY Acad Sci 1994;732:303-314.
44. Kuschner I, Mackiewicz A. Acute phase proteins as disease markers. Disease Markers 1987;5:1-11.
45. Wasil M, Halliwell B, Moorhouse CP. Scavenging of hypochlorous acid by tetracycline, rifampicin and some other antibiotics: A possible antioxidant action of rifampicin and tetracycline. Biochem Pharmacol 1981;37:775-784.
46. Gabler WL, Creamer HR. Suppression of human neutrophil functions by tetracyclines. J Periodont Res 1991;26:52-58.
47. Ramamurthy NS, Vernillo AT, Greenwald RA, et al. Reactive oxygen species activate and tetracyclines inhibit rat osteoblast collagenase. J Bone Min Res 1993;8:1247-1253.
48. 2-macroglobulin with matrix metalloproteinases and its use for identification of their active forms. Ann NY Acad Sci 1994;732:294-302.
49. Greenwald RA. Treatment of destructive disorders with MMP inhibitors: Potential role of tetracyclines. Ann NY Acad Sci 1994;732:181-198.
50. Thomas J, Crout RJ, Crout RM, et al. Antibiotic resistance evaluation with low-dose doxycycline (LDD) in adult periodontitis. J Dent Res 1995;74 (Spec. Issue):575(Abstr. 1394).
51. Ganu V, Doughty J, Spirito S, Goldberg R. Elevation of urinary pyridinoline in adjuvant arthritic rats and its inhibition by doxycycline. Ann NY Acad Sci 1994;732:416-418.
52. Greenwald RA, Moak SA, Golub LM. Low dose doxycycline inhibits pyridinoline excretion in selected patients with rheumatoid arthritis. Ann NY Acad Sci 1994;732:419-421.
53. Petrinec D, Liao S, Holmes DR, Reilly JM, Parks WC, Thompson RW. Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: Preservation of aortic elastin associated with suppressed production of 92-kD gelatinase. J Vase Surg 1996;23:336-346.
54. Crout R, Schroeder K, Wiener M. Low-dose doxycycline (LDD): Potential adjunctive therapy in adult periodontitis (AP). J Periodontol 1994;65:978 (Abstr.).